medytox 086900 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 086900 Date
Period 3 months 100-m won
2016.12 2017.12 2018.12 Average 2019.03 2019.06 2019.09 2019.12 2020.03 2020.06
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 1,333 1,812 2,054 1,733 443 550 484 583 479 507 515
O-profit 752 870 855 826 158 113 33 -46 -7 20 65
N-income 592 700 698 663 136 103 29 -12 3 64 64
O-rate 56.4 48.0 41.6 48.7 35.7 20.5 6.8 -7.9 -1.4 4.0 13.8
N-rate 44.4 38.6 34.0 39.0 30.7 18.7 6.0 -2.1 0.6 12.7 13.3
ROE 40.1 35.6 27.1 34.3 20.2 17.8 14.1 12.6 13.0 14.6 16.2
Debt-ratio 119.4 93.8 53.6 89.0 49.8 52.9 55.9 60.4 63.2 66.1 54.8
Quick-ratio 80.3 66.7 85.6 77.5 90.4 75.0 72.0 64.0 61.1 58.9 75.4
reserve-ratio 6,667.9 8,789.3 10,971.4 8,809.5 11,062.1 11,393.1 11,500.0 11,317.2 11,405.0 11,493.4 11,318.1
EPS 9,904 11,711 11,677 11,097 2,275 1,723 485 -201 66 526 1,071
BPS 24,710 32,874 43,028 33,537 44,952 44,701 44,885 43,949 44,061 44,173 44,622
Dividends 1,887 2,075 849 1,604
2020-05-11
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ -26 %
High mid ~ -35 %
Mid ~ -45 %
Low mid ~ -54 %
Low price ~ -63 %
Indication price Range Current stock price Company score
106,911 W 106,911 W 91,310 W
91,310 W 91,310 W 75,709 W Evaluation
122,512 W 122,512 W~ 106,911 W
164,600 W
36.375,709 W 75,709 W 60,109 W
High price
Sell
60,109 W 60,109 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Chemistry 79 30 3,119 378
60,109원
75,709원
91,310원
106,911원
122,512원
High price
164,600원
-63%
-54%
-45%
-35%
-26%
-70%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
0W
20,000W
40,000W
60,000W
80,000W
100,000W
120,000W
140,000W
160,000W
180,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
medytox
Gap
medytox

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 086900 Date
Period
Gap
(Indication /
stock)
Color
2020-05-11
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
164,600 W High price 45.4 Sell 666,666 W
Suggested Purchase
Amount 170,527 W
Number of stocks
purchased 1
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 122,512 W 122,512 W~ ~ 106,911 W -26 % 43,603 W 0
High mid 106,911 W 106,911 W ~ 91,310 W -35 % 59,766 W 1
Mid 91,310 W 91,310 W ~ 75,709 W -45 % 75,929 W 1
Low mid 75,709 W 75,709 W ~ 60,109 W -54 % 92,092 W 1
low price 60,109 W 60,109 W ~ 0 W -63 % 108,254 W 2
Stock price rise
probability score
A Sector 46.6 48.4 46.9 51.5 42.5 52.0
45.4B Sector 27.1 51.3 18.3 51.5 36.3 44.6
Total average
2019.12.09 2020.01.09 2020.02.10 2020.03.09 2020.04.06 2020.05.08
36.8 49.8 32.6 23.3 39.4 48.3
41 % 19 %
2020.01.09 2020.02.10 2020.03.09 2020.04.06 2020.05.08
Total of
increase rate
Total score
A Sector 4 % -3 % 9 % -21 % 18 %
-1 % 49.0B Sector 47 % -180 % 64 % -42 % 19 %
Total average 26 % -53 % -40 %
47 48 47
51
42
52
27
51
18
51
36
45
37
50
33
23
39
48
0
10
20
30
40
50
60
2019.12.09 2020.01.09 2020.02.10 2020.03.09 2020.04.06 2020.05.08
Stock price rise probability score
A sector
B sector
Total average
4% -3%
9%
-21%
18%
47%
-180%
64%
-42%
19%26%
-53%
-40%
41%
19%
-200%
-150%
-100%
-50%
0%
50%
100%
2020.01.09 2020.02.10 2020.03.09 2020.04.06 2020.05.08
Increase rate of stock price rise
A sector
B sector
Total average
medytox

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report